Union for International Cancer Control

Union for International Cancer Control
Name	Union for International Cancer Control
Formation	1933
Headquarters	Geneva, Switzerland
Type	International non-governmental organization

Contents

Union for International Cancer Control

The Union for International Cancer Control is an international non-governmental organization based in Geneva that coordinates global efforts to reduce the burden of cancer by convening World Health Organization partners, national cancer societies, oncology researchers, and cancer control advocates. Founded in 1933, the organization connects stakeholders from institutions such as International Agency for Research on Cancer, American Cancer Society, European Society for Medical Oncology, Johns Hopkins Hospital and National Cancer Institute to share guidelines, capacity building, and surveillance tools. Its activities intersect with initiatives led by United Nations, World Health Assembly, GAVI, Bill & Melinda Gates Foundation, and regional networks including African Union and Pan American Health Organization.

History

The organization was established in 1933 in response to efforts by physicians and activists associated with League of Nations health debates, early 20th-century oncology pioneers such as Marie Curie, and societies like the British Medical Association and Society of Surgical Oncology. In the post‑World War II era the body engaged with World Health Organization constituent activities, collaborating with research centers including Institut Gustave Roussy, Dana-Farber Cancer Institute, and Memorial Sloan Kettering Cancer Center. During the late 20th century it expanded membership by partnering with national groups like Cancer Research UK, Canadian Cancer Society, and Australian Cancer Council while aligning programs with global meetings such as the World Cancer Congress and scientific symposia hosted alongside International Agency for Research on Cancer. Recent decades saw engagement with policymaking at forums like the UN General Assembly, collaboration with philanthropic actors such as Wellcome Trust, and involvement in capacity initiatives across regions including Sub-Saharan Africa, Southeast Asia, and Latin America.

The mission emphasizes reducing cancer incidence and mortality through evidence-based control strategies promoted to stakeholders including oncologists at institutions such as Royal Marsden Hospital, Peter MacCallum Cancer Centre, and Karolinska Institutet, public health authorities represented by Ministry of Health (various nations), and civil society groups like St. Jude Children's Research Hospital partners. Objectives include strengthening cancer registries analogous to work at International Agency for Research on Cancer's Cancer Registry, advocating for access to essential medicines listed by World Health Organization and aligning with global targets set at the UN High-Level Meeting on Non-Communicable Diseases. The organization promotes standards for treatment and prevention drawn from evidence produced by research centers such as Fred Hutchinson Cancer Center and collaborative trials coordinated with consortia like European Organisation for Research and Treatment of Cancer.

Governance is organized through an international board and regional committees analogous to structures used by International Federation of Red Cross and Red Crescent Societies, with elected officers drawn from member organizations including national societies like Japan Cancer Association, specialty groups such as Union for European Football Associations (note: member collaborations with sporting organizations for advocacy), and institutional partners like Harvard Medical School. Membership categories encompass global, regional, and affiliate bodies similar to those of World Medical Association, engaging academic partners like University of Oxford, research centers like Max Planck Society, and charitable foundations such as Fondation ARC. The secretariat operates from Geneva and liaises with treaty bodies including World Health Assembly delegations and regional offices such as WHO Regional Office for Europe.

Programs include the biennial World Cancer Congress series, training and capacity initiatives modeled after programs at Centers for Disease Control and Prevention, and measurement projects to expand cancer surveillance in partnership with the International Agency for Research on Cancer and national registries in countries such as India, Brazil, and South Africa. Initiatives target tobacco control aligned with Framework Convention on Tobacco Control implementation, access to radiotherapy and chemotherapy informed by guidance from International Atomic Energy Agency and WHO Model List of Essential Medicines, and survivorship programs coordinated with entities like European Cancer Organisation. The organization publishes standards, toolkits, and position statements developed with input from societies such as American Society of Clinical Oncology, Society for Immunotherapy of Cancer, and patient groups including Union for International Cancer Control-affiliated networks.

Advocacy efforts engage multilateral actors including the United Nations, World Health Organization, and regional blocs such as the African Union, while forming partnerships with foundations like the Bill & Melinda Gates Foundation, industry stakeholders represented by International Federation of Pharmaceutical Manufacturers & Associations, and research consortia including Global Alliance for Vaccines and Immunization. Campaigns have aligned with global observances such as World Health Day and policy initiatives like the UN Political Declaration on Non-Communicable Diseases, leveraging collaborations with academic institutions like University College London and advocacy NGOs such as Amref Health Africa and PATH.

Funding derives from diversified sources including grants from philanthropic organizations such as the Wellcome Trust and Robert Wood Johnson Foundation, membership fees from national societies including Cancer Council Australia and Ligue Nationale Contre le Cancer, sponsorships from corporations under frameworks similar to Global Health Innovative Technology Fund, and project-based contracts with multilateral agencies like World Health Organization. Financial governance follows non-profit best practices with audited accounts overseen by an independent finance committee drawing expertise from institutions such as International Monetary Fund advisors and corporate partners including Ernst & Young and KPMG.

Category:International health organizations